Selection events operating at various stages in B cell development

被引:104
作者
Rolink, AG [1 ]
Schaniel, C [1 ]
Andersson, J [1 ]
Melchers, F [1 ]
机构
[1] Basel Inst Immunol, CH-4005 Basel, Switzerland
关键词
D O I
10.1016/S0952-7915(00)00205-3
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
B cells have to progress through various checkpoints during their process of development. The three transcription factors E2A, EBF (early B cell factor) and Pax5 play essential roles in B cell commitment checkpoints. The various forms of the BCR and their downstream signaling molecules, which are expressed at different stages of B cell development, act as critical checkpoint guards allowing (positive selection) or preventing (negative selection) developmental progression. The recent advances on the molecular mechanisms operating at these various checkpoints are here summarized and discussed.
引用
收藏
页码:202 / 207
页数:6
相关论文
共 62 条
[1]   STIMULATION BY T-CELL INDEPENDENT ANTIGENS CAN RELIEVE THE ARREST OF DIFFERENTIATION OF IMMATURE AUTO-REACTIVE B-CELLS IN THE BONE-MARROW [J].
ANDERSSON, J ;
MELCHERS, F ;
ROLINK, A .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1995, 42 (01) :21-33
[2]   E2A PROTEINS ARE REQUIRED FOR PROPER B-CELL DEVELOPMENT AND INITIATION OF IMMUNOGLOBULIN GENE REARRANGEMENTS [J].
BAIN, G ;
MAANDAG, ECR ;
IZON, DJ ;
AMSEN, D ;
KRUISBEEK, AM ;
WEINTRAUB, BC ;
KROP, I ;
SCHLISSEL, MS ;
FEENEY, AJ ;
VANROON, M ;
VANDERVALK, M ;
TERIELE, HPJ ;
BERNS, A ;
MURRE, C .
CELL, 1994, 79 (05) :885-892
[3]   Terminal deoxynucleotidyl transferase and repertoire development [J].
Benedict, CL ;
Gilfillan, S ;
Thai, TH ;
Kearney, JF .
IMMUNOLOGICAL REVIEWS, 2000, 175 :150-157
[4]  
Ceredig R, 2000, EUR J IMMUNOL, V30, P759, DOI 10.1002/1521-4141(200003)30:3<759::AID-IMMU759>3.0.CO
[5]  
2-M
[6]   Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression [J].
Chang, CH ;
Guerder, S ;
Hong, SC ;
vanEwijk, W ;
Flavell, RA .
IMMUNITY, 1996, 4 (02) :167-178
[7]   SYK TYROSINE KINASE REQUIRED FOR MOUSE VIABILITY AND B-CELL DEVELOPMENT [J].
CHENG, AM ;
ROWLEY, B ;
PAO, W ;
HAYDAY, A ;
BOLEN, JB ;
PAWSON, T .
NATURE, 1995, 378 (6554) :303-306
[8]   Immunoglobulin kappa chain receptor editing in systemic lupus erythematosus [J].
Dörner, T ;
Foster, SJ ;
Farner, NL ;
Lipsky, PE .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (04) :688-694
[9]  
Engel H, 1999, EUR J IMMUNOL, V29, P2167, DOI 10.1002/(SICI)1521-4141(199907)29:07<2167::AID-IMMU2167>3.0.CO
[10]  
2-H